Covenant Partners’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,225
| Closed | -$225K | – | 186 |
|
|
2023
Q1 | $225K | Buy |
2,225
+282
| +15% | +$28.5K | 0.09% | 165 |
|
|
2022
Q4 | $232K | Buy |
+1,943
| New | +$232K | 0.09% | 155 |
|
|
2021
Q2 | – | Sell |
-2,055
| Closed | -$200K | – | 204 |
|
|
2021
Q1 | $200K | Buy |
+2,055
| New | +$200K | 0.08% | 195 |
|
|
2020
Q4 | – | Sell |
-2,225
| Closed | -$214K | – | 193 |
|
|
2020
Q3 | $214K | Buy |
+2,225
| New | +$214K | 0.1% | 179 |
|